Table 1.

Patient outline

Case number	Prior grade of oral mucositis	Regimen	Regimen duration/q (in weeks)	Treatment phase	Gender	Age	PS	Dose reduction
1	3	FOLFIRI + Bmab	2	First line	Male	68	0	5-FU
2	3	FOLFIRI + Bmab	2	First line	Female	75	2	5-FU
3	2	FOLFOX + Bmab	2	First line	Male	59	0
4	2	FOLFOX + Bmab	2	First line	Male	73	1
5	2	FOLFOX + Bmab	2	First line	Female	82	1	5-FU
6	2	FOLFOX + Bmab	2	First line	Female	84	1
7	2	FOLFOX + Bmab	2	Second line	Female	67	0
8	2	TS-1 + Cmab	3	Second line	Female	59	1
9	2	TS-1 + Cmab	3	First line	Male	76	0	S-1
10	2	FOLFOX + Bmab	2	First line	Male	63	0
11	2	FOLFIRI + Bmab	2	First line	Female	73	1
12	2	FOLFIRI + Bmab	2	First line	Female	73	1
13	2	FOLFIRI + Bmab	2	Second line	Female	63	0
14	2	XELOX + Bmab	3	First line	Male	74	1	Capecitabine
15	2	XELOX + Bmab	3	First line	Female	75	1
16	2	FOLFIRI + Bmab	2	First line	Male	66	0
17	2	FOLFIRI + Bmab	2	Second line	Female	76	0
18	1	FOLFOX + Bmab	2	First line	Female	62	0
19	1	FOLFIRI + Bmab	2	First line	Male	61	0
20	1	FOLFOX + Bmab	2	First line	Male	44	0
21	1	FOLFIRI	2	First line	Male	66	0
22	1	FOLFIRI + Bmab	2	Second line	Female	59	0